372 related articles for article (PubMed ID: 28790817)
1. Emerging pharmaceutical therapies for COPD.
Lakshmi SP; Reddy AT; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2017; 12():2141-2156. PubMed ID: 28790817
[TBL] [Abstract][Full Text] [Related]
2. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
3. COPD: current therapeutic interventions and future approaches.
Barnes PJ; Stockley RA
Eur Respir J; 2005 Jun; 25(6):1084-106. PubMed ID: 15929966
[TBL] [Abstract][Full Text] [Related]
4. Development of new drugs for COPD.
Barnes PJ
Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
[TBL] [Abstract][Full Text] [Related]
5. New therapies for chronic obstructive pulmonary disease.
Barnes PJ
Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
[TBL] [Abstract][Full Text] [Related]
6. COPD: is there light at the end of the tunnel?
Barnes PJ
Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
[TBL] [Abstract][Full Text] [Related]
7. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
8. Treating systemic effects of COPD.
Cazzola M; Matera MG; Rogliani P; Page C
Trends Pharmacol Sci; 2007 Oct; 28(10):544-50. PubMed ID: 17897727
[TBL] [Abstract][Full Text] [Related]
9. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
Thomson NC
Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
[TBL] [Abstract][Full Text] [Related]
10. Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation.
Loukides S; Bartziokas K; Vestbo J; Singh D
Curr Drug Targets; 2013 Feb; 14(2):235-45. PubMed ID: 23256720
[TBL] [Abstract][Full Text] [Related]
11. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
12. Systemic manifestations and comorbidities of COPD.
Barnes PJ; Celli BR
Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
[TBL] [Abstract][Full Text] [Related]
13. Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease.
Buhl R; Farmer SG
Proc Am Thorac Soc; 2005; 2(1):83-93. PubMed ID: 16113474
[TBL] [Abstract][Full Text] [Related]
14. New treatments for COPD.
Ngkelo A; Adcock IM
Curr Opin Pharmacol; 2013 Jun; 13(3):362-9. PubMed ID: 23602653
[TBL] [Abstract][Full Text] [Related]
15. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
Li J; Dai A; Hu R; Zhu L; Tan S
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852
[TBL] [Abstract][Full Text] [Related]
17. Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).
Ti H; Zhou Y; Liang X; Li R; Ding K; Zhao X
J Med Chem; 2019 Jul; 62(13):5944-5978. PubMed ID: 30682248
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients.
Holownia A; Mroz RM; Skopinski T; Kolodziejczyk A; Chyczewska E; Braszko JJ
Adv Exp Med Biol; 2013; 756():9-14. PubMed ID: 22836613
[TBL] [Abstract][Full Text] [Related]
19. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
